EUVIMEDEUVIMED entdecken
Crossref

Natural history and long-term outcomes of medically managed Type B intramural hematoma

Venkata Vineeth Vaddavalli, Parvathi B Wilkins, Melinda S Schaller, Jonathan J Morrison, Fahad Shuja, Jill J Colglazier, Bernardo C Mendes, Todd E Rasmussen, Manju Kalra, Randall R DeMartino

Journal of Vascular Surgery · 2024

DOI: 10.1016/j.jvs.2024.04.069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Venkata Vineeth Vaddavalli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Hematoma, Disease Progression, Aortic Dissection. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Type B intramural hematoma (IMH) is often managed medically, yet may progress to dissection, aneurysmal dilation, or rupture. The aim of this study was to report the natural history of medically managed Type B IMH, and factors associated with progression. METHODS: We reviewed patients with medically managed Type B IMH between January 1995 to December 2022 at a single center. Any patients with immediate surgical or endovascular intervention were excluded. Demographic profiles, comorbidities, imaging, and follow-up details were reviewed. Patients were divided into two groups: Group 1 had isolated IMH, and Group 2 had IMH along with aneurysm or dissection at the time of presentation. On follow-up, progression was defined as degeneration to aneurysm/dissection or increase in the thickness of IMH in Group 1. In Group 2, progression was an increase in the size of aneurysm or development of new dissection. RESULTS: Of 104 patients with Type B IMH during the study period, 92 were medically managed. The median age was 77 years, and 45 (48.9%) were females. Comorbidities included hypertension (83.7%), hypercholesterolemia (44.6%), and active smoking (47.8%). Mean Society for Vascular Surger comorbidity score was 6.3. Mean IMH thickness and aortic diameter at presentation were 8.9 mm and 38.3 mm, respectively. Median follow-up was 55 months. Overall survival at 1 year and 5 years was 85.8% and 61.9%, respectively. During follow-up, 19 patients (20.7%) required intervention, more common in Group 2 (Group 1, 8/66; 12.3% vs Group 2, 11/26; 42.3%; P = .001). This resulted in higher freedom from intervention in Group 1 at 1 year (93.5% vs 62.7%) and 5 years (87.5% vs 51.1%; P 7.2 mm is associated with both increased odds of progression (odds ratio, 3.3; 95% confidence interval, 1.2-11.1; P = .03) and intervention (odds ratio, 5.5; 95% confidence interval, 1.3-36.9; P = .03) during the follow-up. CONCLUSIONS: Although many patients with Type B IMH managed medically stabilize or regress, progression or need for intervention can occur in up to 40% of cases. This is associated with the presence of aneurysm, dissection, and IMH thickness. Long-term follow-up is mandatory as late interventions occur, particularly for higher risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HematomaDisease ProgressionAortic DissectionHumansFemaleMaleAgedRetrospective StudiesTime FactorsRisk FactorsAged, 80 and overMiddle AgedTreatment OutcomeRisk AssessmentAortic Rupture

Stichwörter der Autor:innen

Aortic dissectionIntramural hematomaMedical managementNatural historyOutcomes

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN.
  • Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN. Electronic address: demartino.randall@mayo.edu.

Zitieren

APA

Vaddavalli, V. V., Wilkins, P. B., Schaller, M. S., Morrison, J. J., Shuja, F., Colglazier, J. J., Mendes, B. C., Rasmussen, T. E., Kalra, M., & DeMartino, R. R. (2024). Natural history and long-term outcomes of medically managed Type B intramural hematoma. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.04.069

Vancouver

Vaddavalli VV, Wilkins PB, Schaller MS, Morrison JJ, Shuja F, Colglazier JJ, et al. Natural history and long-term outcomes of medically managed Type B intramural hematoma. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.04.069

BibTeX
@article{Vaddavalli2024,
  author = {Vaddavalli, Venkata Vineeth and Wilkins, Parvathi B and Schaller, Melinda S and Morrison, Jonathan J and Shuja, Fahad and Colglazier, Jill J and Mendes, Bernardo C and Rasmussen, Todd E and Kalra, Manju and DeMartino, Randall R},
  title = {Natural history and long-term outcomes of medically managed Type B intramural hematoma},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  doi = {10.1016/j.jvs.2024.04.069}
}
Kostenlos starten →